How are they Solving it?
Alytix developed a bacteriophage platform for the design of products for treating bacterial infections, including antibiotic-resistant ones.
Bacteriophage are natural-occurring bacterial predators, capable of specifically attacking and killing them. Compared to antibiotics, bacteriophages generate no resistance and have no side effects. They are continuously pursuing the enhancement of the bacteriophage properties by genetic engineering, leading to better ways to treat diseases.
Alytix have the necessary know-how for the development of many kinds of products against any kind of target bacteria, through a bacteriophage platform to improve health, with in-lab engineering for a better future.